#06-5558 Accrd Manual V7 - COLA

CYTOLOGY>761. EA comparison of all gynecologic cytology reports with a diagnosis of high-grade squamous intraepitheliallesion (HSIL), adenocarcinoma, or other malignant neoplasms with histopathology reports, if they are availablein the laboratory (or in storage)?762. EDetermination of the causes of discrepancies between the cytology and, when available, histopathology diagnosesin these cases?The laboratory is encouraged to complete the reviews noted above prior to release of the cytology report ifpossible giving consideration to any impact on the timely reporting of results.763. EFor each patient with a current classification of high-grade squamous intraepithelial lesion (HSIL), adenocarcinoma,or other malignant neoplasm, is there a review of all of that patient’s negative or normal cytology specimensduring the past five years, if available in the laboratory?764. EFor each patient with a current classification of high-grade squamous intraepithelial lesion (HSIL), adenocarcinoma,or other malignant neoplasm, if significant discrepancies that will affect current care are identified uponreview of previously reported examinations, does the laboratory notify the patient’s physician and issueamended reports?765. EDo all corrected or amended reports issued by the laboratory indicate the basis for the change in the report?766. EAre records of initial examinations and all review results documented and retained by the laboratory?Does the laboratory maintain statistical records which are summarized yearly and include at least:767. EThe number of cytology cases examined and reported?768. EThe number of cases of different specimen types?769. EThe number of cases in different diagnostic categories, including the number reported as unsatisfactory fordiagnostic interpretations?770. EThe number of gynecologic cases diagnosed as high-grade squamous intraepithelial lesion (HSIL), adenocarcinoma,or other malignant neoplasm which have histopathology available for comparison?771. EThe number of cases with discrepant cytology and histology results?772. EThe number of re-screened negative or normal gynecologic cases reclassified as lowgrade squamous intraepitheliallesion (LSIL), high-grade squamous intraepithelial lesion (HSIL), adenocarcinoma, or other malignantneoplasm?. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .FOR MORE INFORMATION CONTACT COLA PHONE 800.981.9883 | FAX 410.381.8611 | ON-LINE www.cola.org89